PMID- 35938305
OWN - NLM
STAT- MEDLINE
DCOM- 20221020
LR  - 20221020
IS  - 1600-0404 (Electronic)
IS  - 0001-6314 (Print)
IS  - 0001-6314 (Linking)
VI  - 146
IP  - 5
DP  - 2022 Nov
TI  - Miller Fisher syndrome following COVID-19 vaccines: A scoping review.
PG  - 604-609
LID - 10.1111/ane.13687 [doi]
AB  - BACKGROUND AND PURPOSE: Miller Fisher syndrome (MFS), a variant of Guillain-Barre 
      Syndrome (GBS), could be underestimated in evaluations of its adverse events 
      (AEs) following COVID-19 vaccination. We aimed to identify and characterize MFS 
      following COVID-19 vaccination. MATERIALS AND METHODS: Relevant studies reported 
      on during the COVID-19 pandemic were identified in the MEDLINE, Embase, and other 
      databases. RESULTS: Nine cases of MFS following COVID-19 vaccination from various 
      regions were included. Unlike MFS following COVID-19 infection, patients with MFS 
      following COVID-19 vaccination frequently presented with anti-GQ1b antibody 
      positivity (44%, 4/9). Unlike GBS following COVID-19 vaccination, only two of 
      nine (22%) cases of MFS following COVID-19 vaccination had developed after 
      viral-vector-related vaccine administration. CONCLUSIONS: Miller Fisher syndrome 
      following COVID-19 vaccination seems to have a different pathophysiology from MFS 
      following COVID-19 infection and GBS following COVID-19 vaccination. This 
      neurological syndrome with a rare incidence and difficulty in diagnosis should be 
      considered an AE of COVID-19 vaccination.
CI  - (c) 2022 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
FAU - Kim, Jee-Eun
AU  - Kim JE
AUID- ORCID: 0000-0002-3811-3479
AD  - Department of Neurology, Ewha Womans University College of Medicine, Seoul, 
      Korea.
FAU - Yoon, Byeol-A
AU  - Yoon BA
AUID- ORCID: 0000-0002-4350-3551
AD  - Department of Neurology, Dong-A University College of Medicine, Busan, Korea.
AD  - Peripheral Neuropathy Research Center, Dong-A University, Busan, Korea.
FAU - Kim, Yoo Hwan
AU  - Kim YH
AUID- ORCID: 0000-0002-9532-5769
AD  - Department of Neurology, Hallym University College of Medicine, Chuncheon, Korea.
FAU - Kim, Jong Kuk
AU  - Kim JK
AUID- ORCID: 0000-0001-9204-3718
AD  - Department of Neurology, Dong-A University College of Medicine, Busan, Korea.
AD  - Peripheral Neuropathy Research Center, Dong-A University, Busan, Korea.
FAU - Bae, Jong Seok
AU  - Bae JS
AUID- ORCID: 0000-0002-4313-1786
AD  - Department of Neurology, Hallym University College of Medicine, Chuncheon, Korea.
LA  - eng
GR  - This study was supported by grant no. 2020-16 from the Kangdong Sacred Heart 
      Hospital Fund (J. S. B.)/
PT  - Journal Article
PT  - Review
DEP - 20220808
PL  - Denmark
TA  - Acta Neurol Scand
JT  - Acta neurologica Scandinavica
JID - 0370336
RN  - 0 (COVID-19 Vaccines)
SB  - IM
MH  - Humans
MH  - *COVID-19/prevention & control
MH  - *COVID-19 Vaccines/adverse effects
MH  - *Guillain-Barre Syndrome/etiology
MH  - *Miller Fisher Syndrome/chemically induced
MH  - Pandemics
PMC - PMC9539325
OTO - NOTNLM
OT  - COVID-19 vaccine
OT  - Guillain-Barre syndrome
OT  - adverse effects
OT  - miller Fisher syndrome
OT  - systematic review
COIS- The authors have no potential conflicts of interest to disclose.
EDAT- 2022/08/09 06:00
MHDA- 2022/10/18 06:00
PMCR- 2022/08/08
CRDT- 2022/08/08 04:20
PHST- 2022/07/26 00:00 [revised]
PHST- 2022/07/01 00:00 [received]
PHST- 2022/07/31 00:00 [accepted]
PHST- 2022/08/09 06:00 [pubmed]
PHST- 2022/10/18 06:00 [medline]
PHST- 2022/08/08 04:20 [entrez]
PHST- 2022/08/08 00:00 [pmc-release]
AID - ANE13687 [pii]
AID - 10.1111/ane.13687 [doi]
PST - ppublish
SO  - Acta Neurol Scand. 2022 Nov;146(5):604-609. doi: 10.1111/ane.13687. Epub 2022 Aug 
      8.